Obesity and metabolic inflammation
- PMID: 24003334
- PMCID: PMC3758492
- DOI: 10.1016/j.ddmec.2013.03.006
Obesity and metabolic inflammation
Abstract
Obesity epidemics affect 35.7% of adults and approximately 17% of children in the United States. Obesity has been associated with several health disorders, such as type 2 diabetes, cardiovascular diseases, fatty liver disease, and certain forms of cancer. Medical costs associated with obesity were estimated at $147 billion in 2008. Chronic tissue inflammation, particularly in adipose tissue, has been considered as a key underlying mechanism for the development of obesity-related metabolic syndrome. In this review, we discuss the recent progress in the field of metabolic inflammation and the potential implication of anti-inflammation approaches as therapeutic interventions for treating obesity-related metabolic disorders.
Keywords: WAT; inflammation; obesity.
Conflict of interest statement
The author declares no conflict of interest.
Figures
References
-
- Hotamisligil GS, et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259 (5091):87–91. - PubMed
-
- Gao Z, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 2002;277 (50):48115–48121. - PubMed
-
- Lee YH, et al. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem. 2003;278 (5):2896–2902. - PubMed
-
- Schipper HS, et al. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab. 2012;23 (8):407–415. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources